Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Fabio Busato"'
Autor:
Mario Caccese, Fabio Busato, Angela Guerriero, Marta Padovan, Giulia Cerretti, Marina Paola Gardiman, Vittorina Zagonel, Giuseppe Lombardi
Publikováno v:
Cancer Medicine, Vol 12, Iss 15, Pp 16041-16053 (2023)
Abstract Meningiomas are the most prevalent tumors of the central nervous system. Their standard treatment is surgery, which can be curative. Adjuvant radiotherapy treatment is reserved for newly diagnosed cases of grade II and grade III meningiomas
Externí odkaz:
https://doaj.org/article/53cf372d5de84f09a332c495cadef43a
Autor:
Jacopo Lolli, Francesca Tessari, Franco Berti, Marco Fusella, Davide Fiorentin, Davide Bimbatti, Umberto Basso, Fabio Busato
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/a6b59fb4c5e14aa4b7dd6537ffce6ec6
Autor:
Jacopo Lolli, Francesca Tessari, Franco Berti, Marco Fusella, Davide Fiorentin, Davide Bimbatti, Umberto Basso, Fabio Busato
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionRadionecrosis is a consequence of SRS (stereotactic radiosurgery) for brain metastases in 34% of cases, and if symptomatic (8%–16%), it requires therapy with corticosteroids and bevacizumab and, less frequently, surgery. Oncological ind
Externí odkaz:
https://doaj.org/article/022f880afaed409e9dcd7f8631cc9873
Autor:
Valentina Baro, Giulia Cerretti, Michela Todoverto, Alessandro Della Puppa, Franco Chioffi, Francesco Volpin, Francesco Causin, Fabio Busato, Pasquale Fiduccia, Andrea Landi, Domenico d’Avella, Vittorina Zagonel, Luca Denaro, Giuseppe Lombardi
Publikováno v:
Current Oncology, Vol 29, Iss 5, Pp 3472-3488 (2022)
Glioblastomas with multiple foci at presentation (mGBMs) account for 2–35% of all GBMs. mGBMs have limited existing data and no standardized treatment. This study aims to determine their incidence, demographic and clinical features, outcome, and pr
Externí odkaz:
https://doaj.org/article/9c92787a12c64ea78a05e1b011152a29
Autor:
Elisa Palumbo, Celeste Piotto, Enrica Calura, Elena Fasanaro, Elena Groff, Fabio Busato, Badr El Khouzai, Michele Rigo, Laura Baggio, Chiara Romualdi, Demetre Zafiropoulos, Antonella Russo, Maddalena Mognato, Luigi Corti
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Introduction: Adverse effects of radiotherapy (RT) significantly affect patient's quality of life (QOL). The possibility to identify patient-related factors that are associated with individual radiosensitivity would optimize adjuvant RT treatment, li
Externí odkaz:
https://doaj.org/article/ec2cb9201ae24518a319114e29d5ee32
Autor:
Gaia Griguolo, Vittoria Aldegheri, Michele Bottosso, Alice Pittaro, Francesca Caumo, Maria Cristina Guarascio, Stéphane Pouderoux, Fabio Busato, Federica Miglietta, William Jacot, Maria Vittoria Dieci, Amelie Darlix, Valentina Guarneri
Publikováno v:
International Journal of Cancer.
Publikováno v:
International journal of molecular sciences. 23(18)
Cancer treatment with ionizing radiation (IR) is a well-established and effective clinical method to fight different types of tumors and is a palliative treatment to cure metastatic stages. Approximately half of all cancer patients undergo radiothera
Autor:
Elena Fasanaro, Paola Del Bianco, Elena Groff, Antonella Riva, Giovanna Petrangolini, Fabio Busato, Paola Stritoni, Giovanni Scarzello, Lucio Loreggian, Gian Luca De Salvo
Publikováno v:
Cancers; Volume 14; Issue 24; Pages: 6192
Background: In patients affected by head and neck squamous cell carcinoma, the onset of severe oral mucositis is a decisive factor in completing concurrent chemo-radiotherapy, and few interventions have demonstrated a modest benefit. The primary aim
Autor:
Giulia Cerretti, Luisa Bellu, Mario Caccese, Vittorina Zagonel, F. Berti, Giuseppe Lombardi, Alessandro Parisi, Fabio Busato, Marta Padovan
Publikováno v:
Journal of Cancer Metastasis and Treatment.
Autor:
Eric Deutsch, Christine Haie-Meder, Fabio Busato, Philippe Morice, Patricia Pautier, Cyrus Chargari, Sebastien Gouy, Roger Sun, Catherine Genestie, K. Holub, Albert Biete, Alexandra Leary
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 1441, p 1441 (2020)
Journal of Clinical Medicine
Volume 9
Issue 5
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Clinical Medicine
Volume 9
Issue 5
Dipòsit Digital de la UB
Universidad de Barcelona
Background: The causal link between elevated systemic inflammation biomarkers and poor survival has been demonstrated in cancer patients. However, the evidence for this correlation in endometrial cancer (EC) is too weak to influence current criteria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52df7201213e229c22e7dd4361fe0230
http://hdl.handle.net/2445/174867
http://hdl.handle.net/2445/174867